Cart
sales@molnova.com
Ibandronate sodium
CAS No. 138844-81-2
Ibandronate sodium( —— )
Catalog No. M11612 CAS No. 138844-81-2
Ibandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 34 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 72 | In Stock |
|
| 50MG | 91 | In Stock |
|
| 100MG | 117 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 294 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIbandronate sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionIbandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
-
DescriptionIbandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHAP| FPS
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number138844-81-2
-
Formula Weight341.21
-
Molecular FormulaC9H22NNaO7P2
-
Purity>98% (HPLC)
-
SolubilityFree soluble in Water
-
SMILESO.[Na+].[Na+].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dunford JE, et al. J Pharmacol Exp Ther. 2001 Feb; 296(2):235-42.
molnova catalog
related products
-
Bay 41-4109 racemate
The racemate form of Bay 41-4109, which is a potent, non-nucleosidic inhibitor of HBV nucleocapsid maturation with IC50 of 0.05 uM.
-
Metacavir
Metacavir (PNA) is a novel nucleoside reverse transcriptase inhibitor, a deoxyguanosine analog, with anti-hepatitis B virus (HBV) activity and mitochondrial toxicity, which can be used to study HBV infection.
-
RO6889678
RO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.
